NCT02144233

Brief Summary

The primary endpoint will be the average change in pain score from baseline to the three- and six-month assessments. Efficacy will be demonstrated by superior pain relief with the active treatment compared with the placebo.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
77

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 19, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 21, 2014

Completed
2 months until next milestone

Study Start

First participant enrolled

August 1, 2014

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2018

Completed
1.9 years until next milestone

Results Posted

Study results publicly available

April 22, 2020

Completed
Last Updated

April 22, 2020

Status Verified

April 1, 2020

Enrollment Period

3.9 years

First QC Date

May 19, 2014

Results QC Date

March 25, 2019

Last Update Submit

April 11, 2020

Conditions

Keywords

PainTemporomandibular joint disordersOcclusal adjustmentTherapyRandomized clinical trialMasticationHabitual chewing sideHandedness preferenceJaw asymmetry

Outcome Measures

Primary Outcomes (1)

  • Jaw-pain-Intensity (Affected Side)

    Self-reported affected-side pain-intensity across the trial in a 0-10 visual analogue scale (VAS) (0=no pain, 10=worst possible pain). Higher values represent a worse outcome.

    Baseline and 6-months

Secondary Outcomes (3)

  • Chewing Side

    Baseline and 6-months

  • Change in Global Severity Index Scores (Symptom Checklist-90-Revised (SCL-90-R))

    Baseline, 6-Months

  • Maximum Unassisted Jaw Opening

    Baseline, 3- and 6-Months

Other Outcomes (20)

  • Headache-intensity

    Baseline 3- and 6-Months

  • Number of Participants With Neuropathic Pain

    Baseline, 6-Months

  • Handedness Preference

    Baseline

  • +17 more other outcomes

Study Arms (2)

Occlusal adjustment therapy

EXPERIMENTAL

Occlusal adjustment therapy consists of the elimination of premature tooth contacts during retruded jaw closure, and the reduction of the steeper lateral anterior guidance; the magnitude of this alteration will be estimated by the following equation: (right condylar path) × (left anterior guidance) = (left condylar path) × (right anterior guidance). A resin-composite, placed mainly in the canine tooth, can be used to increases the flatter lateral guidance on the habitual chewing side; overcorrection is expected to compensate for a masticatory preference on the opposite side to the handedness.

Procedure: Occlusal adjustment

Placebo occlusal adjustment therapy

PLACEBO COMPARATOR

Placebo occlusal adjustment will take place in a manner identical to the real adjustment. However, a specially fabricated inactive rotary instrument will be used, and no enamel will be removed.

Procedure: Placebo occlusal adjustment

Interventions

The first step consists of the elimination of premature tooth contacts during retruded jaw closure. The second step included reduction of the steeper lateral anterior guidance; the magnitude of this alteration will be estimated by the following equation: (right condylar path) × (left anterior guidance) = (left condylar path) × (right anterior guidance)

Also known as: Occlusal reshaping, Selective grinding of teeth, Restoring physiological jaw-closure, Restoring impaired chewing function
Occlusal adjustment therapy

Placebo occlusal adjustment will take place in a manner identical to the real adjustment. However, a specially fabricated inactive rotary instrument will be used, and no enamel will be removed.

Placebo occlusal adjustment therapy

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Completely dentate (except for the third molars; including if they were treated before enrollment by conventional or implant-supported fixed prosthesis allowing similar potential comfortable chewing on both sides)
  • Normal Angle Class I occlusion
  • Self-reported pain-intensity scores from 4 to 9 in a 0-10 visual analogue scale (VAS) or numerical pain rating scale (NRS).
  • Chronic (over 6 months) joint and/or muscle pain, according to diagnostic criteria for temporomandibular disorders (DC/TMD), for which they had requested therapy

You may not qualify if:

  • Psychosis
  • Major depression
  • Substance abuse
  • Cognitive impairment
  • Addiction to morphine or derivates
  • Litigation or asking for disability/retirement compensation for chronic pain
  • Dental care professionals
  • Orthodontic therapy during the last 2 years
  • Patients with any pain that is more severe, in the same location as, or cannot be clearly distinguished from TMD pain
  • Individuals for whom minimally invasive occlusal adjustment could not achieve occlusal equilibration, including: Over 2 mm of difference between the maximal intercuspal position and the centric occlusion or over 4 mm of difference between upper and lower archs (or over 2mm on at less one side) measured: between the mesial fosses of first upper premolars with respect the buccal cusps of the first lower premolars; and/or between the mesiopalatal cusp of the first upper molars respect to the central (mesial) fossae of the first lower molar.
  • Severe periodontal disease with grade 3 mobility

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Universidad de Santiago de Compostela

Santiago de Compostela, A Coruña, Galicia, 15782, Spain

Location

Complexo Hospitalario Universitario A Coruña

A Coruña, A Coruña. Galicia, 15006, Spain

Location

Related Publications (1)

  • Santana-Mora U, Lopez-Cedrun J, Mora MJ, Otero XL, Santana-Penin U. Temporomandibular disorders: the habitual chewing side syndrome. PLoS One. 2013 Apr 8;8(4):e59980. doi: 10.1371/journal.pone.0059980. Print 2013.

    PMID: 23593156BACKGROUND

MeSH Terms

Conditions

Temporomandibular Joint Dysfunction SyndromeChronic PainPainTemporomandibular Joint Disorders

Interventions

Occlusal Adjustment

Condition Hierarchy (Ancestors)

Craniomandibular DisordersMandibular DiseasesJaw DiseasesMusculoskeletal DiseasesJoint DiseasesMuscular DiseasesMyofascial Pain SyndromesStomatognathic DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Orthodontics, CorrectiveOrthodonticsDentistry

Results Point of Contact

Title
Professor Urbano Santana Penín
Organization
University of Santiago de Compostela. A Coruña. SPAIN

Study Officials

  • Urbano Santana-Penin, Prof

    University of Santiago de Compostela

    PRINCIPAL INVESTIGATOR
  • Jose Lopez-Cedrun, Dr

    University Hospital Complex of La Coruña

    STUDY CHAIR
  • Maria J Mora, Prof

    University of Santiago de Compostela

    STUDY DIRECTOR
  • Urbano Santana-Mora, Dr

    University of Santiago de Compostela

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Prof.

Study Record Dates

First Submitted

May 19, 2014

First Posted

May 21, 2014

Study Start

August 1, 2014

Primary Completion

June 15, 2018

Study Completion

June 15, 2018

Last Updated

April 22, 2020

Results First Posted

April 22, 2020

Record last verified: 2020-04

Data Sharing

IPD Sharing
Will share

A closed, certificate, database called OpenClinica allows access to members of the Data and Safety Monitoring Board. We expect to publish raw data in Sci Data. Figures from participant's mouth could be posted in a repository. The protocol will be attached as a supplementary appendix to the main manuscript

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
The raw data of each participant, unidentifiable, will be accessible within 6 months after the publication of the manuscript and will be accessible for at least one year.
Access Criteria
Free access

Locations